Table 1.
FEP patients with persistent AVH (n = 18) | Healthy controls (n = 18) | p value | |
---|---|---|---|
Age (mean ± s.d.) | 27.14 ± 5.66 | 26.94 ± 4.31 | 0.91 |
Gender (Male/female) | 15/3 | 15/3 | 0.73 |
Marital status (single/married) | 18/0 | 16/2 | 0/492 |
CPZ equivalents (mean ± s.d.) | 217.85 ± 139.51 | ||
Duration of untreated psychosis (days) (mean ± s.d.) | 323.92 ± 311.23 | ||
BAVQ-R scores | |||
Malevolence (mean ± s.d.) | 11.07 ± 4.54 | ||
Benevolence (mean ± s.d.) | 4.00 ± 3.28 | ||
Omnipotence (mean ± s.d.) | 11.57 ± 4.32 | ||
Resistance (mean ± s.d.) | 19.36 ± 3.67 | ||
Engagement (mean ± s.d.) | 5.21 ± 3.98 | ||
TVRS scores (mean ± s.d.) | 17.71 ± 3.47 | ||
VPDS scores (mean ± s.d.) | 22.93 ± 5.44 | ||
PSYRATS (auditory hallucination subscale) | |||
Total score (mean ± s.d.) | 26.86 ± 4.95 | ||
Emotional domain (mean ± s.d.) | 11.29 ± 3.42 | ||
Cognitive domain (mean ± s.d.) | 8.64 ± 1.82 | ||
Physical domain (mean ± s.d.) | 9.79 ± 1.92 |
FEP first episode psychosis, AVH auditory verbal hallucinations, CPZ chlorpromazine, BAVQ-R belief about voices questionnaire—revised, TVRS topography of Voices Rating Scale, VPDS Voice Power Differential Scale, PSYRATS Psychotic Symptom Rating Scales